Phospholipase A2, Group IIE (PLA2G2E) (Middle Region) Peptide
Quick Overview for Phospholipase A2, Group IIE (PLA2G2E) (Middle Region) Peptide (ABIN981824)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- GIFCAGRTTC QRLTCECDKR AALCFRRNLG TYNRKYAHYP NKLCTGPTPP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PLA2G2E Antibody(ARP47041_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PLA2G2E (Phospholipase A2, Group IIE (PLA2G2E))
-
Background
-
PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.PLA2G2E has a preference for arachidonic-containing phospholipids.
Alias Symbols: -
Protein Size: 142 -
Molecular Weight
- 16 kDa
-
Gene ID
- 30814
-
NCBI Accession
- NM_014589, NP_055404
-
UniProt
- Q9NZK7
Target
-